Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sou Hirose
Observed name:
S. Hirose
Institution:
Jikei University School of Medicine
Observed institutions:
Jikei University School of Medicine,
Keio University,
National Cancer Centre Japan,
Jikei University Kashiwa hospital,
National Cancer Center Research Institute
ORCID:
0000-0002-2803-0557
Observed ORCID:
0000-0002-2803-0557
OpenAlex ID:
A5004120002
Works
21
Awards
1
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients
2019
·
Sou Hirose
, Naoya Murakami
, et al.
·
Gynecologic Oncology
·
54
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
2021
·
Ikumi Kuno
, Daisuke Takayanagi
, et al.
·
Scientific Reports
·
40
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
2021
·
Daisuke Takayanagi
, Sou Hirose
, et al.
·
Cancers
·
37
PDF
Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
2018
·
Sou Hirose
, Hiroshi Tanabe
, et al.
·
Journal of Gynecologic Oncology
·
31
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy
2021
·
Naoya Murakami
, Yuka Asami
, et al.
·
Scientific Reports
·
14
PDF
Gene aberration profile of tumors of adolescent and young adult females
2017
·
Yasuyuki Kanke
, Akihiko Shimomura
, et al.
·
Oncotarget
·
14
PDF
Analysis of risk factors for patients with early‐stage cervical cancer: A study of 374 patients
2020
·
Kazu Ueda
, Nozomu Yanaihara
, et al.
·
Journal of obstetrics and gynaecology research
·
10
O3C Glass-Class: A Machine-Learning Framework for Prognostic Prediction of Ovarian Clear-Cell Carcinoma
2022
·
Ryo Yokomizo
, Tiago JS Lopes
, et al.
·
Bioinformatics and Biology Insights
·
9
Phase I/II clinical study of next-generation photodynamic therapy (L-PDT) using talaporfin sodium (Laserphyrin®) for cervical intraepithelial neoplasia: Efficacy, safety, and fertility preservation
2026
·
Masaru Sakamoto
, Shuji Takeda
, et al.
·
Photodiagnosis and Photodynamic Therapy
·
6
P184 Differential pathologic response from primary systemic chemotherapy across breast cancer intrinsic subtypes
2011
·
H. Jinno
, S. Matsuda
, et al.
·
The Breast
·
3
[A Case of Abdominal Wall Hernia Rupture during Bevacizumab Treatment].
2015
·
Satoshi Sugimoto
, Yasuaki Miyazaki
, et al.
·
PubMed
·
2
361 Psoas muscle volume is predictive factor for poor survival in elderly ovarian cancer patients
2020
·
Y. Tomita
, M. Takenaka
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
The relationship of HOXB9 expression promoting tumor cell proliferation and angiogenesis to clinical outcomes of patients with breast cancer.
2011
·
T. Hayashida
, H. Jinno
, et al.
·
Journal of Clinical Oncology
·
1
Gynecological and obstetrical outcomes of phase I /II study of photodynamic therapy using talaporfin sodium (LaserphyrinR) and diode laser (L-PDT) for Cervical Intraepithelial Neoplasia.
2025
·
Masaru Sakamoto
, Shuji Takeda
, et al.
·
Photodiagnosis and Photodynamic Therapy
429 Identification of clinicopathological prognostic factors in recurrent endometrial cancer
2020
·
Y. Koike
, M. Takenaka
, et al.
·
International Journal of Gynecological Cancer
PDF
328 Clinicopathological significance of FOXL2 and TERT promoter mutations in adult type granulosa cell tumor of the ovary
2020
·
Y. Shoburu
, S. Yanagida
, et al.
·
International Journal of Gynecological Cancer
PDF
Impact of genomic alterations and HPV genotypes on clinical outcomes of Japanese patients with locally advanced cervical cancer
2019
·
I. Kuno
, D. Takayanagi
, et al.
·
Annals of Oncology
Retrospective Analysis on Recurrent Sites in 602 Stage I Ovarian Cancer
2016
·
Sou Hirose
IS-AC-1-4 Retrospective analysis on recurrent sites in 603 stage I ovarian cancer(Group 1 Oncology 1,International Session Award Candidate)
2016
·
Sou Hirose
, Hiroshi Tanabe
, et al.
·
日本産科婦人科學會雜誌
Aosp9 Hoxb9, a Gene Promoting Tumour Angiogenesis and Proliferation, Is Significantly Associated With Poor Clinical Outcomes in Er-positive Breast Cancer Patients
2013
·
H. Seki
, T. Hayashida
, et al.
·
European Journal of Cancer
1445 POSTER HOXB9, a Gene Promoting Tumour Angiogenesis and Proliferation, is a Novel Prognostic Biomarker in Human Breast Cancer
2011
·
H. Seki
, T. Hayashida
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
21
Citation count:
222
H-index:
8
I10-index:
7
Year
Topic
Type